Resolvin D1/N-formyl peptide receptor 2 ameliorates paclitaxel-induced neuropathic pain through the activation of IL-10/Nrf2/HO-1 pathway in mice
Cited by 26
Related Papers
DYRK1A inhibitors for disease therapy: Current status and perspectives
|European Journal of Medicinal Chemistry|2021|103
Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment
|Frontiers in Pharmacology|2022|29
IDH2-mediated regulation of the biogenesis of the oxidative phosphorylation system
|Science Advances|2022|25